Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2019-10-02 Tax Withholding | 2019-10-04 2:10 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 2,396 | $0.23 | 103,552 (Direct) | View |
2019-08-06 Option Award | 2019-08-08 4:44 pm | N/A 2027-07-26 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 181,808 | $0 | 302,366 (Direct) | View |
2019-08-06 Disposition | 2019-08-08 4:44 pm | N/A 2028-06-01 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 131,808 | $0 | 302,366 (Direct) | View |
2019-08-06 Option Award | 2019-08-08 4:42 pm | N/A 2027-12-01 | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 138,100 | $0 | 174,048 (Direct) | View |
2019-08-06 Disposition | 2019-08-08 4:42 pm | N/A 2027-12-01 | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 68,100 | $0 | 174,048 (Direct) | View |
2019-08-06 Option Award | 2019-08-08 4:40 pm | N/A 2027-07-26 | Sienna Biopharmaceuticals Inc. | SNNA | Lizzul Paul F. Chief Medical Officer | 175,550 | $0 | 327,595 (Direct) | View |
2019-08-06 Disposition | 2019-08-08 4:40 pm | N/A 2028-06-01 | Sienna Biopharmaceuticals Inc. | SNNA | Lizzul Paul F. Chief Medical Officer | 120,550 | $0 | 327,595 (Direct) | View |
2019-08-06 Option Award | 2019-08-08 4:38 pm | N/A 2027-07-26 | Sienna Biopharmaceuticals Inc. | SNNA | Beddingfield III Frederick President & CEO | 611,968 | $0 | 1,542,181 (Direct) | View |
2019-08-06 Disposition | 2019-08-08 4:38 pm | N/A 2028-06-01 | Sienna Biopharmaceuticals Inc. | SNNA | Beddingfield III Frederick President & CEO | 461,968 | $0 | 1,542,181 (Direct) | View |
2019-07-02 Tax Withholding | 2019-07-03 1:47 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Stroehmann Diane See Remarks | 4,095 | $0.76 | 168,545 (Direct) | View |
2019-07-02 Tax Withholding | 2019-07-03 1:42 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 4,095 | $0.76 | 120,558 (Direct) | View |
2019-07-02 Tax Withholding | 2019-07-03 1:39 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Lizzul Paul F. Chief Medical Officer | 4,095 | $0.76 | 152,045 (Direct) | View |
2019-07-02 Tax Withholding | 2019-07-03 1:36 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 1,552 | $0.76 | 35,948 (Direct) | View |
2019-07-02 Tax Withholding | 2019-07-03 1:35 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Beddingfield III Frederick President & CEO | 17,063 | $0.76 | 930,213 (Direct) | View |
2019-05-30 Option Award | 2019-06-03 7:41 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Burow Kristina Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
2019-05-30 Option Award | 2019-06-03 7:38 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | MORE ROBERT J Director | 25,000 | $0 | 25,000 (Direct) | View |
2019-05-30 Option Award | 2019-06-03 7:35 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Leonard Keith R Director | 25,000 | $0 | 25,000 (Direct) | View |
2019-05-30 Option Award | 2019-06-03 7:32 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Hindman James M. Director | 25,000 | $0 | 25,000 (Direct) | View |
2019-05-30 Option Award | 2019-06-03 7:29 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Harris Todd Director | 25,000 | $0 | 25,000 (Direct) | View |
2019-05-30 Option Award | 2019-06-03 7:24 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | FENTON DENNIS M Director | 25,000 | $0 | 25,000 (Direct) | View |